Globus Medical (GMED) PT Raised to $103 at Barclays

February 24, 2025 9:11 AM

Barclays analyst Matt Miksic raised the price target on Globus Medical (NYSE: GMED) to $103.00 (from $100.00) while maintaining a Overweight rating.

No results found